BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37880458)

  • 21. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
    Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway.
    Zhang Z; Zhang Y; Zhang R
    Med Oncol; 2023 Jan; 40(2):70. PubMed ID: 36588128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
    Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
    Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
    Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
    Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
    Li H; Jin X; Zhang Z; Xing Y; Kong X
    Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. piRNA-31115 Promotes Cell Proliferation and Invasion via PI3K/AKT Pathway in Clear Cell Renal Carcinoma.
    Du X; Li H; Xie X; Shi L; Wu F; Li G; Lai C; Heng B
    Dis Markers; 2021; 2021():6915329. PubMed ID: 34790278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma.
    Zhu Y; Liu X; Wang Y; Pan Y; Han X; Peng B; Zhang X; Niu S; Wang H; Ye Q; Gu Y; Gao S
    Cell Death Dis; 2022 May; 13(5):456. PubMed ID: 35562342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin-specific peptidase 46 (USP46) suppresses renal cell carcinoma tumorigenesis through AKT pathway inactivation.
    Gui D; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
    Biochem Biophys Res Commun; 2019 Nov; 519(4):689-696. PubMed ID: 31542232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway.
    Zhao Z; Liu H; Hou J; Li T; Du X; Zhao X; Xu W; Xu W; Chang J
    Oncol Res; 2017 May; 25(5):773-779. PubMed ID: 27983909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ETV4 is a theranostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent manner.
    Xu L; Hu H; Zheng LS; Wang MY; Mei Y; Peng LX; Qiang YY; Li CZ; Meng DF; Wang MD; Liu ZJ; Li XJ; Huang BJ; Qian CN
    Cancer Lett; 2020 Jul; 482():74-89. PubMed ID: 32305558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma.
    Wang ZR; Wei JH; Zhou JC; Haddad A; Zhao LY; Kapur P; Wu KJ; Wang B; Yu YH; Liao B; He DL; Chen W; Margulis V; Hsieh JT; Luo JH
    Oncotarget; 2016 May; 7(21):31508-19. PubMed ID: 27129174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
    Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
    Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma.
    Amend B; Hennenlotter J; Scharpf M; Kruck S; Kuehs U; Senger E; Merseburger AS; Kuczyk MA; Sievert KD; Stenzl A; Bedke J
    World J Urol; 2012 Jun; 30(3):353-9. PubMed ID: 21822918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OTUD1 stabilizes PTEN to inhibit the PI3K/AKT and TNF-alpha/NF-kappaB signaling pathways and sensitize ccRCC to TKIs.
    Liu W; Yan B; Yu H; Ren J; Peng M; Zhu L; Wang Y; Jin X; Yi L
    Int J Biol Sci; 2022; 18(4):1401-1414. PubMed ID: 35280681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIR2DL4 promotes the proliferation of RCC cell associated with PI3K/Akt signaling activation.
    Ding XF; Chen J; Ma HL; Liang Y; Wang YF; Zhang HT; Li X; Chen G
    Life Sci; 2022 Mar; 293():120320. PubMed ID: 35063466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
    Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
    Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
    Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.